Microfluidic technologies for accelerating the clinical translation of nanoparticles

Microfluidic technologies for accelerating the clinical translation of nanoparticles

Using nanoparticles for therapy and imaging holds tremendous promise for the treatment of major diseases such as cancer. However, their translation into the clinic has been slow because it remains difficult to produce nanoparticles that are consistent 'batch-to-batch', and in sufficient qu...

Full description

Bibliographic Details
Main Authors: Langer, Robert (Contributor), Valencia, Pedro Miguel (Contributor), Farokhzad, Omid C. (Contributor), Karnik, Rohit (Contributor)
Other Authors: MIT-Harvard Center for Cancer Nanotechnology Excellence (Contributor), Massachusetts Institute of Technology. Institute for Medical Engineering & Science (Contributor), Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Massachusetts Institute of Technology. Department of Mechanical Engineering (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: Nature Publishing Group, 2013-07-01T19:54:13Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items